Personal CFO Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Sell
68,233
-233
-0.3% -$6.2K 0.27% 64
2025
Q4
$1.7M Sell
68,466
-670
-1% -$16.9K 0.27% 61
2025
Q3
$1.76M Buy
69,136
+1,376
+2% +$34K 0.31% 59
2025
Q2
$1.64M Sell
67,760
-17,404
-20% -$406K 0.3% 60
2025
Q1
$2.16M Buy
85,164
+60
+0.1% +$1.57K 0.44% 44
2024
Q4
$2.26M Sell
85,104
-3,726
-4% -$101K 0.44% 42
2024
Q3
$2.57M Sell
88,830
-7,763
-8% -$226K 0.36% 55
2024
Q2
$2.7M Buy
96,593
+20,764
+27% +$572K 0.42% 48
2024
Q1
$2.1M Buy
75,829
+1,711
+2% +$47.5K 0.33% 59
2023
Q4
$2.13M Buy
74,118
+5,545
+8% +$168K 0.37% 51
2023
Q3
$2.27M Sell
68,573
-1,136
-2% -$40.2K 0.45% 47
2023
Q2
$2.56M Sell
69,709
-1,024
-1% -$39.9K 0.52% 36
2023
Q1
$2.89M Buy
70,733
+2,270
+3% +$98K 0.6% 32
2022
Q4
$3.51M Buy
68,463
+11,009
+19% +$528K 0.74% 30
2022
Q3
$2.51M Sell
57,454
-30,990
-35% -$1.51M 0.63% 33
2022
Q2
$4.64M Sell
88,444
-3,439
-4% -$175K 1.09% 19
2022
Q1
$4.76M Buy
91,883
+5,031
+6% +$261K 0.94% 22
2021
Q4
$5.13M Buy
86,852
+44,984
+107% +$2.23M 0.96% 20
2021
Q3
$1.8M Buy
41,868
+5,989
+17% +$265K 0.37% 51
2021
Q2
$1.41M Sell
35,879
-1,282
-3% -$49.9K 0.29% 70
2021
Q1
$1.35M Buy
37,161
+10,167
+38% +$361K 0.29% 68
2020
Q4
$994K Sell
26,994
-5,053
-16% -$185K 0.25% 96
2020
Q3
$1K Buy
32,047
+9,734
+44% +$341K 0.33% 106
2020
Q2
$692K Buy
22,313
+8,750
+65% +$297K 0.2% 100
2020
Q1
$420K Buy
13,563
+1,533
+13% +$52.2K 0.15% 137
2019
Q4
$448K Sell
12,030
-2,436
-17% -$86.8K 0.13% 162
2019
Q3
$598K Buy
+14,466
New +$526K 0.24% 104

Other funds holding PFE

Personal CFO Solutions's PFE Position: Q1 2026 in Review

Personal CFO Solutions reduced its Pfizer (PFE) stake by 0.34% in Q1 2026, selling an estimated $6.2K and leaving 68,233 shares worth $1.92M. The position accounts for 0.27% of the portfolio, ranked #64.

Personal CFO Solutions first reported a position in PFE in Q3 2019 and has held it in 27 quarters since. The position peaked at $5.13M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Personal CFO Solutions held 68,233 shares of Pfizer worth $1.92M as of Q1 2026.
  • Personal CFO Solutions sold 233 Pfizer shares in Q1 2026, an estimated $6.2K.
  • Pfizer made up 0.27% of Personal CFO Solutions's portfolio in Q1 2026, its #64 holding.
  • Personal CFO Solutions first reported a position in Pfizer in Q3 2019 and has held it in 27 quarters since.
  • Personal CFO Solutions's Pfizer position peaked at $5.13M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.